fileAI Signs Strategic Collaboration Agreement with AWS to Accelerate Rollout of Outcome-Driven AI Agents for BFSI Leaders

Beyond the Label of Solo Motherhood: TECNO and Angélica Dass Launch the Philippines Portrait Gallery for 100 Portraits of Becoming

MERGER VOTE ALERT: The M&A Class Action Firm Is Investigating the Merger Vote -- UTZ, SAFT, PASG and FNWD

Global Times: 'He felt he was coming home': US art historian James Cahill’s daughter remembers his dialogue with China

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class...

ROSEN, TRUSTED TRIAL ATTORNEYS, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -...

Heybike Launches V1 Pro, a 72V Power Beast with 8,000W Peak Power and Bigger Attitude

Heybike Launches V1 Pro, a 72V Power Beast with 8,000W Peak Power and Bigger Attitude

NCPL Investors Have Opportunity to Lead Netcapital Inc. Securities Fraud Lawsuit with SBS Law

Global Times: 30 hours to a satellite captures the essence of ‘Xiong’an speed’

ROSEN, REGARDED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action...

Cardinal Point Wealth Management Examines U.S. Citizenship Considerations for Cross-Border Families

Build-A-Bear Investor News: If You Have Suffered Losses in Build-A-Bear Workshop, Inc., You Are Encouraged to Contact The Rosen Law Firm...

Tin Men Capital leads US$7.4M Series A for Vision AI startup Ailytics to expand across APAC, US and Gulf

Nasdaq Strengthens Asia-Pacific Leadership Team

ROSEN, TRUSTED TRIAL ATTORNEYS, Encourages D-Wave Quantum Inc. Investors to Secure Counsel Before Important Deadline in Securities Class...

FFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia's Investor Weekly Report to October 26

Results of CARsgen's Satri-cel for Adjuvant Treatment for Gastric Cancer Presented at ESMO Congress 2026

FTK Investors Have Opportunity to Lead Flotek Industries, Inc. Securities Fraud Lawsuit with SBS Law

Ascletis Announces FDA IND Submission of ASC39, an Oral Small Molecule Selective Amylin Receptor Agonist for the Treatment of Obesity